Semaglutide Research Overview (Ireland)

Peptides Lab Ireland research team · Research overview · Updated October 2026

This page is a plain-English overview of semaglutide as a laboratory research compound: what it is, how it acts at the receptor level, what published preclinical studies have investigated, and how to store and handle it in the lab.

What semaglutide is

Semaglutide is a synthetic analogue of human glucagon-like peptide-1 (GLP-1). It is a 31-amino acid peptide (molecular weight about 4113.6 Da) based on GLP-1(7-37). Two changes set it apart from the native hormone: an Aib substitution at position 8, which makes it resistant to the enzyme DPP-IV, and a C18 fatty diacid attached at Lys26 through a linker, which lets it bind reversibly to albumin. Together these give it a much longer half-life than native GLP-1 in pharmacokinetic studies.

Mechanism of action

Semaglutide is a selective agonist of the GLP-1 receptor, a class B G protein-coupled receptor. Receptor activation raises intracellular cAMP through Gs signalling, which in pancreatic beta cells potentiates glucose-dependent insulin secretion. GLP-1 receptors are also found in the hypothalamus and brainstem, the gut, the heart and the kidney, so researchers use semaglutide to study GLP-1 receptor signalling in each of these tissues.

What published studies have investigated

• Molecular design: the medicinal chemistry work that produced semaglutide, including how the fatty acid side chain affects albumin binding and receptor potency (Lau et al., 2015, PubMed 26308095).
• Central signalling in rodents: how semaglutide reaches and acts on brain regions involved in feeding behaviour in mouse and rat models (Gabery et al., 2020, PubMed 32213703).
• Development history: a review of how liraglutide and semaglutide were developed from native GLP-1 (Knudsen and Lau, 2019, PubMed 31031702).
• Comparative pharmacology: semaglutide is often used as the GLP-1-only reference compound when studying dual and triple agonists. See our GLP-1, tirzepatide and retatrutide comparison.

In cell-based work, studies typically use nanomolar or lower concentrations in assay buffer. Animal-study methods vary between publications; consult the primary literature for study-specific details.

Storage and handling in the laboratory

• Store lyophilised vials at −20 °C, protected from light and moisture.
• Once reconstituted, keep solutions at 2–8 °C, label them with compound, concentration and date, and use within the working window stated on the batch Certificate of Analysis.
• Aliquot stock solutions to avoid repeated freeze/thaw cycles, which degrade peptides.
• Semaglutide’s fatty diacid chain makes it bind albumin; many in vitro protocols include a carrier protein such as BSA to limit losses to plastics.
• For general bench preparation see our reconstitution guide and cold-chain storage guide.

Related pages

• Research-grade semaglutide (product page and batch CoA)
• Semaglutide Ireland research reference
• HPRA regulations and research peptides in Ireland

For laboratory research use only. Research compounds supplied by Peptides Lab Ireland are not medicines, are not intended for human or veterinary use, and this page does not give dosing or administration guidance of any kind.